Serum soluble triggering receptor expressed on myeloid cells-2 was not altered by rTMS in patients with treatment-resistant depression.
Tateishi H, Matsushima J, Kunitake H, Imamura Y, Kunitake Y, Murakawa T, Mawatari S, Kojima R, Fujii Y, Kikuchi J, Fukuchi J, Sakemura Y, Shiraishi T, Nagahama C, Maekawa T, Asami T, Mizoguchi Y, Monji A.
Tateishi H, et al. Among authors: maekawa t.
Neuropsychopharmacol Rep. 2023 Jun;43(2):222-227. doi: 10.1002/npr2.12332. Epub 2023 Mar 12.
Neuropsychopharmacol Rep. 2023.
PMID: 36907597
Free PMC article.